Packaged Facts reports on a variety of topics that impact pets and the veterinary industry from their U.S. Pet Market Outlook (June 2022) report, based on 2019 – 2022 MRI-Simmons National Consumer Studies.
No Jumps in Dog Population
In the wake of COVID-19, as Packaged Facts reports, MRI-Simmons national consumer survey data continue to show the dog population as roughly flat, whether measured in dog ownership rates or in the total number of dog-owning households).
These MRI-Simmons data similarly show no increase, since the COVID-19 pandemic, in the percentage of U.S. households with puppies under age 1.
Largest Size Dogs Are Gaining Traction
As reported by Packaged Facts, MRI-Simmons data show a continuing trend toward owning the largest dogs, those weighing 61 pounds or more. About 16 million U.S. households own one of more of these largest-size dogs, up from 13.7 million in pre-COVID fall 2019.
Conversely, the trend is away from owning the smallest dogs, those weighing 10 pounds or less. About 10 million households own these smallest dogs, down from 11.6 million in 2019.
For the YTD ending July 31, 2022, year over year reporting showed changes from the previous month’s results among the respective categories ranging from (-0.5%) to 2.8%. Core and Lifestyle vaccine indices for canine and feline patients were at +1.3% growth across the 32,000+ practices and shelter locations in the Animalytix Marketplace. YTD Kennel Cough vaccine purchases, which provide a measure of the pet mobility, were at (-2.6%) growth. Purchases of chronic care medications and surgical consumables were (-4.2%) and (-1.3%) respectively while parasiticide growth is positive at +4.2% YTD compared to PYTD.
Among the VetWatch™ Bellwether reporting zones for Core/Lifestyle Vaccine Purchase growth vs PYTD, the Los Angeles, CA zone leads all markets with +6.0% growth. Growth for the Columbus, OH zone performance was notable at +5.1% while Houston, TX was the laggard in the group at (-2.7%) growth vs PYTD.
*Map displays YTD Core & Lifestyle Vaccines sales courtesy of Animalytix
This week’s totals for reported parasiticide purchases across all segments year to date through the week ending March 6, are ahead of 2020 results by an extremely robust +12.2% among the 32,000+ practices and shelter locations in the Animalytix Marketplace. The most significant YOY change in the market is the +49.7% growth in the canine combination flea and heartworm products (e.g. specifically Simparica Trio), as substitution continues to occurring at the expense of products from the canine flea and tick preventatives which are experiencing a decline softening decline of (-1.9%) YTD. Canine heartworm preventatives purchases moved ahead of 2020’s record strong sales for the same period, posting growth of +2.6%. Feline flea and heartworm preventatives are now ahead of last year at a robust +8.8% growth.
Among the leading “Bellwether” parasiticide market zones, Greenville, SC now leads with +32.0% growth in total parasiticide purchases followed by Philadelphia, PA at +31.8%. Among the lagging “Bellwether” zones is Los Angeles, CA at +1.9% versus the same YTD period in 2020 bringing all “Bellwether” parasiticide market zones into the positive YTD.
*Map displays YTD Canine/Feline F/T/HW Parasiticide sales courtesy of Animalytix
For the week ending July 30, 2022, aggregate YTD practice revenues are at +4.5% net growth versus YTD 2021 for the ~3,000 reporting practices. Period performance growth in unique patients(pets) remains at (-2.2%). Unique client and invoice growth posted (-1.9) and (-2.9%) growth respectively vs PYTD results.
Among the listed “Bellwether” market zones, Philadelphia, PA lead with +10.7% YTD revenue growth while unique patient growth was at +3.6%. St. Louis, MO was notable among the laggard zones, finishing at (-1.9%) revenue growth and (-3.9%) growth in unique patients vs PYTD.
Following more current trends, the national 3-week rolling average for practice revenue growth was at (-2.0%). Two of the nine Census Divisions posted positive revenue growth for the current rolling 3-week average. The rolling 3-week average revenue growth index is designed to provide a more immediate view of growth trends (e.g., market velocity). A positive value indicates rolling revenue growth vs the prior year reported 3-week period.
Map displays YTD total hospital revenue courtesy of Animal Care Technologies
*Indicates Merged Zone Group
© 2022 Animalytix LLC. All rights reserved. Animalytix is a registered trademark and ALYX and Market Sensus are service marks of Animalytix LLC. All other registered trademarks, trademarks, or service marks cited are the property of their respective owners.
Brought to you by 
This website uses cookies to analyze site traffic. By using this site you consent to our use of cookies. Cookie settings can be managed via your browser settings.
Read our privacy policy by selecting 'Give me more info'.